ABH HealthcareShare price, financial results, shareholding and management

NSE Emerge · ABHHospitalListed 1 Sept 2026IPO ₹102Catch them young
Live price on NSE ↗ISIN INE1R2M01019 · Lot 1,200 shares · ₹46,080
₹38.40
-1.50% on the day
Close · 19 Nov 2026
Valuation
Market cap
₹44 cr
Stock P/E
7.8peers 17.7
Book value
₹15.2
Price to book
2.53
EV / operating profit
-
Market cap to sales
0.85
Returns and growth
ROCE · FY26
19.7%
ROE · FY26
38.9%
ROE, 3-year average
42.7%
Operating margin · FY26
28.8%peers 16.9%
Sales growth, 3 years
20.9%
Profit growth, 3 years
99.5%
Safety
Debt to equity
3.17peers 0.16
Borrowings
₹55 cr
Interest cover
2.8×
Cash from business / op. profit
14%
Debtor days
234
Pledged
0.00%
Ownership and share
Promoter holding
69.99%
Change in promoter holding
-
Shareholders
1,124
High / low since listing
₹99 / ₹38
Dividend yield
0.00%
Face value
₹10

Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.

ABH Healthcare share price chart

₹38.40-59.17% since listing

Close on 19 Nov 2026 · -1.54% on the day · Vol 22,800

Daily prices to 19 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.

Share price returns

To the close of 19 Nov 2026

1 month
-10.1%
Since IPO
-62.4%
Traded a day, 20 days
₹0.08 cr
Taken for delivery
79%

Business growth

Sales and net profit, from the reported results

SalesProfit
FY26 on FY25+6%+5%
3 years, a year+21%+100%

About ABH Healthcare: business, products and customers

ABH Healthcare runs the Anil Baghi Hospital, a multi speciality hospital in Ferozepur, Punjab, for patients who pay themselves, through insurance or through government health schemes. Its shares trade on NSE Emerge.

The Anil Baghi Hospital was set up in 1985 with thirty beds and was taken over by the company in March 2022 from the proprietorship of Dr. Kamal Baghi. It now has 150 beds, of which 70 are ICU beds, and offers 25 specialities; internal medicine and critical care bring in about half of revenue, with cardiology, general surgery and orthopaedics next. The pharmacy inside the hospital is outsourced, so the company books only its share of pharmacy income.

Revenue is the number of beds in use times what each occupied bed earns a day, plus out-patient fees, while staff, doctors and equipment cost much the same whether beds are full or not. Beds were added faster than patients came, so occupancy fell even as revenue per bed rose. More than half of revenue now comes from government schemes and public sector payers, which pay over time, so money owed to the hospital has climbed and cash from operations has stayed well below profit.

Read more about the business

Two partnerships in which the company holds 90% extend the hospital: Five Creeks Healthcare runs dialysis for patients under the Ayushman Bharat Sarbat Sehat Bima Yojana, and ABH Clinics runs the first off campus out-patient clinic. The offer document compares the company with the listed hospital companies Sangani Hospitals, Maitreya Medicare and Asarfi Hospital, all small hospital operators, and says it competes with government hospitals and private hospitals and clinics in its region.

From the offer document (Red Herring Prospectus, August 2026) and the company's exchange announcements.

Read the deeper study ↓

In its favour

  • Sales have grown fast: 21% a year over three years.
  • The promoters own a large part of the company: 69.99%.

To watch

  • Receivable days against the company's estimate of about 200 days for FY27 (Offer document, p.95).
  • Addition of the 30 beds the board approved within the existing premises (Offer document, p.128).
  • Use of the issue money set aside for unidentified acquisitions (Offer document, p.88).
  • The company secretary's exit announced on 8 October 2026 and the change in auditors announced on 12 October 2026 (Exchange announcements).
  • Customers take longer to pay than before: 234 days in FY26, against 24 in FY22.

From the company's documents first, then the reported figures read by fixed rules, the same for every company. Facts, not a view on the shares.

ABH Healthcare revenue and profit growth

Half-yearly results · Profit and loss

Sales have grown fast. Last year profit grew roughly in step with sales.

Sales and net profit, every year, ₹ crore
SalesNet profit
0204060Sales, FY22: 3.5 ₹ cr3.5Net profit, FY22: 0.1 ₹ cr0.1FY22Sales, FY23: 29.2 ₹ cr29.2Net profit, FY23: 0.7 ₹ cr0.7FY23Sales, FY24: 39.9 ₹ cr39.9Net profit, FY24: 1.7 ₹ cr1.7FY24Sales, FY25: 48.6 ₹ cr48.6Net profit, FY25: 5.4 ₹ cr5.4FY25Sales, FY26: 51.6 ₹ cr51.6Net profit, FY26: 5.6 ₹ cr5.6FY26

ABH Healthcare profit and loss

Full years to March, FY22 to FY26 · ₹ crore, consolidated where reported

₹ crore
FY22FY23FY24FY25FY26
Sales3.5029.1939.9348.5551.60
Expenses3.2725.1232.2935.3636.76
Operating profit0.234.077.6413.1914.84
OPM6.6%13.9%19.1%27.2%28.8%
Other income0-0.02-0.730.05-0.04
Interest0.041.332.963.714.48
Depreciation0.071.561.742.102.39
Profit before tax0.121.162.217.437.93
Tax rate33.3%38.8%24.9%28.0%28.9%
Net profit0.090.711.665.355.64
EPS ₹93.558.3026.707.06
Dividend payout0.0%0.0%0.0%0.0%0.0%

ABH Healthcare profitability

Margins and returns on capital

Last year the company kept about as much from each rupee of sales as the year before. It earns a moderate return on the money it uses.

Operating margin, every year

Per cent of sales kept before interest, depreciation and tax

0%10%20%30%40%FY22: 6.6%6.6%FY22FY23: 13.9%13.9%FY23FY24: 19.1%19.1%FY24FY25: 27.2%27.2%FY25FY26: 28.8%28.8%FY26
Per cent
FY22FY23FY24FY25FY26
Operating margin6.6%13.9%19.1%27.2%28.8%
Tax rate33.3%38.8%24.9%28.0%28.9%
ROCE·10.7%15.2%23.3%19.7%
ROE·29.0%30.0%59.3%38.9%
Dividend payout0.0%0.0%0.0%0.0%0.0%

ABH Healthcare debt and cash flow

Balance sheet · Cash flow · Working capital

The company's own money, its net worth, has grown fast. Its loans are now larger than its own money. Last year the business brought in less cash than it showed as profit, so part of the profit is still to be collected. It spent more on assets and investments than the business brought in, and raised the rest from loans or shares. Customers take longer to pay than they did in FY24, which ties up more of the company's money in unpaid bills.

Its own money and its borrowings, ₹ crore
Net worthBorrowings
0204060Net worth, FY22: 0.2 ₹ cr0.2Borrowings, FY22: 20.6 ₹ cr20.6FY22Net worth, FY23: 4.7 ₹ cr4.7Borrowings, FY23: 21 ₹ cr21FY23Net worth, FY24: 6.4 ₹ cr6.4Borrowings, FY24: 35.8 ₹ cr35.8FY24Net worth, FY25: 11.7 ₹ cr11.7Borrowings, FY25: 41.9 ₹ cr41.9FY25Net worth, FY26: 17.3 ₹ cr17.3Borrowings, FY26: 55 ₹ cr55FY26
Cash from the business against net profit, ₹ crore
Cash from the businessNet profit
-20246Cash from the business, FY22: 3.1 ₹ cr3.1Net profit, FY22: 0.1 ₹ cr0.1FY22Cash from the business, FY23: -1.6 ₹ cr-1.6Net profit, FY23: 0.7 ₹ cr0.7FY23Cash from the business, FY24: 0.9 ₹ cr0.9Net profit, FY24: 1.7 ₹ cr1.7FY24Cash from the business, FY25: 3.5 ₹ cr3.5Net profit, FY25: 5.4 ₹ cr5.4FY25Cash from the business, FY26: 2.1 ₹ cr2.1Net profit, FY26: 5.6 ₹ cr5.6FY26

Bars below the line are cash going out.

ABH Healthcare balance sheet

At each 31 March · ₹ crore

₹ crore
FY22FY23FY24FY25FY26
Equity capital0.102228
Reserves0.092.704.359.699.34
Net worth0.194.706.3511.6917.34
Borrowings20.6220.9735.7941.8855.03
Other liabilities5.467.299.2010.3312.90
Total liabilities26.2732.9651.3463.9085.27
Fixed assets23.4822.7333.8136.6841.92
Capital work in progress00.63000
Investments000.120.291.74
Other assets2.799.6017.4126.9341.61

ABH Healthcare cash flow

₹ crore

₹ crore
FY22FY23FY24FY25FY26
Cash from operations3.06-1.550.893.542.11
Cash from investing-23.55-1.45-13.06-4.53-9.14
Cash from financing20.702.9412.041.589.45
Net cash flow0.21-0.06-0.130.592.42

Working capital

Days

Days
FY22FY23FY24FY25FY26
Debtor days2474110148234
Inventory days···159117
Days payable···242239
Cash conversion cycle247411066113
Working capital days-985-59-1736172

ABH Healthcare peers and competitors

Listed SME companies in the same industry

By sales, ABH Healthcare is number 11 of the 23 listed SME companies in healthcare services.

Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.

CompanyMarket cap ₹ crP/ESales ₹ crProfit ₹ crOp. marginDebt/equity
Nephro Care India14141.988.73.49.4%0.00
Modern Diagnostic & Research Centre9518.183.15.315.4%0.63
Pramodini Medicare25415.0621750.0%0.34
Adeshwar Meditex--56.11.34.9%0.16
ABH Healthcare447.851.65.628.8%3.17
Shanmuga Hospital5713.4454.218.4%0.16
Maitreya Medicare80-44.9-2.5-0.7%0.80
Invicta Diagnostic8417.332.44.930.2%0.07
Nidan Laboratories and Healthcare1912.425.51.519.0%0.16
Aatmaj Healthcare5069.724.30.79.7%0.41
Aashka Hospitals24372.8233.322.8%0.08
Median of the 10 others8417.744.93.416.9%0.16

ABH Healthcare shareholding pattern

Promoters, FIIs, DIIs, HNIs and small holders

The promoters own more than half the company. Big foreign and Indian funds own very little.

Promoters
69.99%
Foreign investors (FIIs)
3.00%
HNIs (over ₹2 lakh each)
0.42%
Small holders (up to ₹2 lakh)
23.71%
Companies and others
2.88%
Number of shareholders
1,124
1,124 in Aug 26

ABH Healthcare shareholding pattern

Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.

Aug 26
Promoters69.99%
Foreign investors (FIIs)3.00%
HNIs (over ₹2 lakh each)0.42%
Small holders (up to ₹2 lakh)23.71%
Companies and others2.88%
Number of shareholders1,124

The named holders are at 31 Aug 2026, each under the group the pattern files them in.

ABH Healthcare study: the business from its own documents

Read from 1 of the company's own documents

ABH Healthcare so far

From the company's own record

  1. 1 Sept 2026Listed on NSE Emerge at ₹102
  2. 17 Sept 2026An order announced
  3. 31 Aug 2026Promoters at 69.99%
  4. 1 Sept 2026Highest close since listing, ₹94.05

ABH Healthcare key facts from the filings

Each figure with the document it comes from

Beds
150
Total bed capacity in FY26, with 125 beds in operation and 70 of them ICU beds; it was 100 in FY24.Offer document, p.128
Bed occupancy
47%
Share of operational bed days used in FY26, down from 49% in FY25 and 63% in FY24 as beds were added.Offer document, p.128
Revenue per occupied bed
₹19,992
Average a day in FY26, up from ₹18,245 in FY25.Offer document, p.128
Government schemes and PSUs
52.40%
Share of FY26 revenue paid through government schemes and public sector payers, up from 43.44% in FY24; self pay fell to 31.85%.Offer document, p.132
Days to get paid
239 days
Trade receivables held in FY26, up from 149 days in FY25; the company estimates about 200 days for FY27.Offer document, p.95
Show 5 more facts
Top two payers
42.51%
Share of FY26 revenue from the two largest payers; the top ten gave 59.15%.Offer document, p.233 to 234
Medical team
37 doctors
At June 2026, 27 full time and 10 part time, with 101 nurses among 309 staff.Offer document, p.142
Debt to equity
2.99
At March 2026, down from 5.69 in FY24; loans carry personal guarantees of the promoters.Offer document, p.128 and p.234 to 235
IPO for loans
₹17.0 cr
Largest planned use of the issue money, with ₹5.0 cr for working capital and the rest for unidentified acquisitions and general purposes.Offer document, p.88
More beds approved
30
Beds the board approved in April 2025 to add within the existing premises.Offer document, p.128

What the company said, and what happened

The company's own statements, attributed, set against what it later reported; not newboard's estimates

The company says the board has approved adding 30 beds within the existing premises, and that it plans urgent care centres in nearby towns, more off campus clinics and growth through asset light arrangements or acquisitions; no acquisition had been agreed at the offer document. It estimates trade receivables of about 200 days in FY27, against 239 days in FY26.

30Beds approved to addBoard, April 2025
200 daysReceivables estimateFY27, offer document

Is it a good business? Six questions

Each answer is about that one question, read from the documents; tap one for the evidence. Not a view on the shares.

ABH Healthcare earns from one established hospital in Ferozepur, where more patients in its beds and more complex care lift income over largely fixed costs.

Its weak spots are a single location, many empty beds after expansion, and slow payment from government schemes.

AverageCan it set its own prices?Revenue per occupied bed has risen, but more than half of revenue comes through government schemes and public sector payers, and the company warns competition could push prices down.
The evidence. Revenue per occupied bed rose to ₹19,992 in FY26 from ₹18,245; government schemes and PSUs gave 52.40% of FY26 revenue.Offer document, p.128, p.132 and p.142
AverageHow strong is it against rivals?It is a long running hospital with accreditation and many specialities, but it competes with government and private hospitals in the same region.
The evidence. Established in 1985, NABH accredited in 2021 and for digital standards in FY25, with 25 specialities; the offer document names government hospitals and private hospitals and clinics as competitors.Offer document, p.127 and p.142
WatchWho are its customers?Patients come from one town and its surroundings, and a large part of the bill is paid by a few government and insurance payers.
The evidence. Top two payers gave 42.51% of FY26 revenue and the top ten 59.15%; the hospital is the only one the company runs.Offer document, p.127 and p.233 to 234
WatchDoes it need a lot of money?Beds and equipment were built on borrowed money, and slow collections tie up more cash as revenue grows.
The evidence. Debt to equity was 2.99 at March 2026 and trade receivables were held for 239 days in FY26.Offer document, p.95 and p.128
AverageCan it keep finding new work?It is tied into insurers and all major government schemes in the region, but occupancy has fallen for two years as beds were added.
The evidence. Empanelled with over 30 insurers and TPAs and schemes including ECHS, Railways, FCI, BSNL and AB-SSBY; occupancy fell from 63% in FY24 to 47% in FY26.Offer document, p.127 and p.128
StrongDo good and bad years swing a lot?Hospital demand is steady through the year, and patient numbers have held up while capacity grew.
The evidence. The offer document says the business is not seasonal or cyclical; in-patient discharges were 5,723, 6,339 and 6,387 over FY24 to FY26.Offer document, p.128 and p.233

Who runs ABH Healthcare?

Promoters, directors and officers; tap a name for the background

DKDr. Kamal BaghiPromoter, Chairman and Whole-time Director · holds 21.00%

Holds a master's degree of medicine from Guru Nanak Dev University and has about four decades in healthcare. Founded Anil Baghi Hospital in 1985 and was a founding member of Anil Baghi School of Nursing, Genesis Institute of Dental Sciences and Research and Anil Baghi College of Nursing. Responsible for the overall management of the company.

Offer document, p.160 to 161
DSDr. Saurabh BaghiPromoter and Managing Director · holds 47.95%

A non-invasive cardiologist with an MBBS from Baba Farid University of Health Sciences, an MD in Internal Medicine from The Brooklyn Hospital Center and a cardiology and heart failure fellowship at Mt. Sinai Hospital, New York; worked as a consultant cardiologist at Parkview Medical Center, Colorado, from 2014 and joined the hospital on return to India in 2020. Managing Director to May 2028. The offer document states Dr. Kamal Baghi is the father of Dr. Saurabh Baghi.

Offer document, p.129, p.160 to 162 and p.163
DVDr. Vaishali SainiPromoter and Non-Executive Director · holds 1.05%

An ABPN certified neurologist with an MBBS from Baba Farid University of Health Sciences, trained in neurology at New York Presbyterian Hospital, Cornell Campus; later Director for stroke at Parkview Medical Center, Colorado. Oversees hiring and training of nursing staff. The offer document states Dr. Vaishali Saini is the spouse of Dr. Saurabh Baghi.

Offer document, p.129 to 130 and p.162
DSDr. Satnam Singh NijjarIndependent Director

Holds a master's degree of surgery from Guru Nanak Dev University and has over 20 years in healthcare; Managing Director of Nijjar Hospitals in Batala. On the board since January 2025.

Offer document, p.161 to 162
BSBalwinder SinghIndependent Director

Holds a BA from Jawaharlal Nehru University and a master's in defence and strategic studies from Madras University; retired from the Indian Army as Major General after over 30 years. On the board since January 2025.

Offer document, p.161 to 162
RARajeev AgarwalChief Financial Officer

A Chartered Accountant with more than three decades in accounts and finance, earlier with Eicher Tractors, Jindal Iron and Steel, Reliance Communications and as CFO of Ivy Hospital. Appointed in February 2025.

Offer document, p.172

ABH Healthcare latest news and announcements

Announcements · Documents · Corporate actions

What changed recently

Each half-year is set against the same half a year earlier

  • 17 Sept 2026: an order announced.

ABH Healthcare annual reports, earnings calls and documents

Every document links to its source; “read” marks those this page is built from

Offer document

ABH Healthcare share split, bonus and dividends

From the corporate actions the company announces on the exchange

No share split, bonus issue or dividend is on record since listing.

Checks we ran on ABH Healthcare's data · 8

Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.

  • ✓Balance sheet totals add up for FY25 and FY26.
  • ✓Market cap uses the share count in the latest shareholding pattern (1,14,29,600 shares).
  • !The FY26 results imply 80,00,000 shares at face value ₹10, which disagrees with the shareholding pattern; the pattern is used.
  • ✓Promoter pledge figures are within possible limits in every shareholding pattern shown.
  • ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
  • !Earnings per share changes basis between FY22 (₹9.00) and FY23 (₹3.55) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
  • ✓Revenue and profit are reported for every year shown, FY22 to FY26.
  • iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.

Questions people ask about ABH Healthcare

What does ABH Healthcare do?

ABH Healthcare runs the Anil Baghi Hospital, a multi speciality hospital in Ferozepur, Punjab, for patients who pay themselves, through insurance or through government health schemes. Its shares trade on NSE Emerge.

What is the share price of ABH Healthcare?

₹38.4 at the close on 19 Nov 2026, from the exchange's daily figures.

What is the market cap of ABH Healthcare?

₹44 cr at the close on 19 Nov 2026, on 1,14,29,600 shares.

What is the P/E of ABH Healthcare?

7.8 times FY26 profit at the close on 19 Nov 2026 (our arithmetic).

What are ABH Healthcare's revenue and profit?

Revenue ₹52 cr and profit after tax ₹6 cr in FY26.

Who are the promoters of ABH Healthcare?

Dr. Kamal Baghi, Dr. Saurabh Baghi, Dr. Vaishali Saini; promoters held 69.99% at 31 Aug 2026.

What was the IPO price of ABH Healthcare?

₹102 a share; it listed on 1 Sept 2026.

More SME companies like ABH Healthcare

Other listed SME companies in healthcare services, the closest in size first, each read from its own documents.

Every listed SME company in Healthcare Services → · SME companies listed in 2026 →

Built from 1 offer document, 10 exchange announcements, 1 shareholding patterns and 5 years of reported results. Every figure carries its source; where the documents are silent, the page says so.